Evidence map›Paper›PMID 28497026›Full record

ArticleFrontiers in oncology2017

CHCHD4 Regulates Intracellular Oxygenation and Perinuclear Distribution of Mitochondria.

Luke W Thomas, Oliver Staples, Mark Turmaine, Margaret Ashcroft

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.1field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. HIF-1 signaling: an emerging mechanism for mitochondrial dynamics.Journal of physiology and biochemistry · 2023
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. CHCHD4 (MIA40) and the mitochondrial disulfide relay system.Biochemical Society transactions · 2021
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Luke W ThomasDepartment of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
Oliver StaplesCentre for Cell Signalling and Molecular Genetics, Division of Medicine, University College London, London, UK.
Mark TurmaineDepartment of Cell and Developmental Biology, University College London, London, UK.
Margaret AshcroftDepartment of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
University College London · GBUniversity of Cambridge · GB

Funding

Cancer Research UK 19442Medical Research Council MR/K002201/1Medical Research Council MR/K002201/2
6 · The paper itself

Abstract

Hypoxia is a characteristic of the tumor microenvironment and is known to contribute to tumor progression and treatment resistance. Hypoxia-inducible factor (HIF) dimeric transcription factors control the cellular response to reduced oxygenation by regulating the expression of genes involved in metabolic adaptation, cell motility, and survival. Alterations in mitochondrial metabolism are not only a downstream consequence of HIF-signaling but mitochondria reciprocally regulate HIF signaling through multiple means, including oxygen consumption, metabolic intermediates, and reactive oxygen species generation. CHCHD4 is a redox-sensitive mitochondrial protein, which we previously identified and showed to be a novel regulator of HIF and hypoxia responses in tumors. Elevated expression of

Indexed as

coiled-coil helix coiled-coil helix domain containing 4hypoxiahypoxia-inducible factor-1αmitochondriamitochondrial localizationperinuclear

Identifiers

PMID28497026
PMCPMC5406405
OpenAlexW2609422218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.